Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Netrod-HTN: Netrod System for Uncontrolled Hypertension
NCT03261375Completed
- Sponsor
- Shanghai Golden Leaf MedTec
- Start
- Jan 2021
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Randomised, double-blind trial in essential hypertension (2 arms), sponsored by Shanghai Golden Leaf MedTec. Primary endpoint: Change in Office Systolic Blood Pressure at 6 months. Started Jan 2021; status: completed.
02
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT03261375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03261375.